Days after Eli Lilly and Company said it would stop a trial of its Covid-19 antibody therapy in hospitalized patients because it was not effective, the company on Wednesday published promising interim results from a trial involving patients with mild and moderate Covid-19.
from CNN.com - RSS Channel - App International Edition https://cnn.it/3e2U19m
via IFTTT
Wednesday, October 28, 2020
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment